North America Immunohistochemistry Market Research Report – Segmented By Product, Application, End User & Country (The United States, Canada & Rest of North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 2737
Pages: 140

North America Immunohistochemistry Market Size (2023 to 2028)

As per our report, the size of the North America Immunohistochemistry Market has been estimated at USD 613.62 million in 2023. It is further estimated to be growing at a CAGR of 7.6% and worth USD 885.03 million by 2028.

The market is expected to show substantial growth during the forecast period as well as in the future years. Immunohistochemistry is a medical procedure that includes staining on a fresh or stored cancer tissue that is removed out during biopsy. This technique assists in the detection of hormone receptors on the surface of cancer cells. Immunohistochemistry is majorly used for the diagnosis of cancers, especially tumor antibodies.

The growth of technology in the biotech market and sudden commercialization are the major drivers for the growth of the market in this region.

The growth is hampered because of its requirement for extremely high capital and long R & D activities. But, the increasing adoption of immunohistochemistry products for the detection of tumors of unknown origin is leading to North America’s dominance.

This research report on North America Immunohistochemistry Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Antibodies
  • Reagents
  • Equipment
  • Kits

By Application: 

  • Diagnostics
  • Drug Testing

By End User: 

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes

By Country: 

  • The United States
  • Canada
  • Rest of North America

Key Participants dominating the North American Immunohistochemistry Market Profiled in the Report are F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Abcam plc, Cell Signaling Technology, Inc., and Bio SB Inc.

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample